Literature DB >> 26346003

A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion.

Masaaki Harada1, Takahiro Oto2, Shinji Otani2, Kentaroh Miyoshi2, Masanori Okada2, Norichika Iga2, Hitoshi Nishikawa2, Seiichiro Sugimoto2, Masaomi Yamane2, Shinichiro Miyoshi2.   

Abstract

OBJECTIVE: Ex vivo lung perfusion (EVLP) has been used not only for graft evaluation but also for graft reconditioning prior to lung transplantation. Inflammatory cells such as neutrophils may cause additional graft injury during EVLP. Neutrophil elastase inhibitors protect lungs against neutrophil-induced lung injury, such as acute respiratory distress syndrome. This study aimed to investigate the effect of a neutrophil elastase inhibitor during EVLP.
METHODS: EVLP was performed for 4 h in bilateral pig lungs that had previously experienced warm ischemia for 2 h with or without a neutrophil elastase inhibitor (treated and control groups, respectively; n = 6). Following EVLP, the left lung was transplanted into a recipient pig, and this was followed by observation for 4 h. Pulmonary functions were observed both during EVLP and during the early post-transplant stage.
RESULTS: During EVLP, decreases in neutrophil elastase levels (P < 0.001), the wet-dry weight ratio (P < 0.05), and pulmonary vascular resistance (P < 0.01) and increases in the PaO2/FiO2 ratio (P < 0.01) and pulmonary compliance (P < 0.05) were observed in the treated group. After transplantation, decreased pulmonary vascular resistance (P < 0.05) was observed in the treated group.
CONCLUSIONS: A neutrophil elastase inhibitor attenuated the inflammatory response during EVLP and may decrease the incidence of lung reperfusion injury after transplantation.

Entities:  

Keywords:  Ex vivo lung perfusion; Lung ischemia/reperfusion injury; Lung transplantation; Neutrophil elastase inhibitor

Mesh:

Substances:

Year:  2015        PMID: 26346003     DOI: 10.1007/s11748-015-0585-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  20 in total

1.  Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster.

Authors:  T Hagio; S Nakao; H Matsuoka; S Matsumoto; K Kawabata; H Ohno
Journal:  Eur J Pharmacol       Date:  2001-08-24       Impact factor: 4.432

2.  Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response.

Authors:  S M Fiser; C G Tribble; S M Long; A K Kaza; J T Cope; V E Laubach; J A Kern; I L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 5.209

3.  Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.

Authors:  Naoya Fujino; Hiroshi Kubo; Tomoko Suzuki; Mei He; Takaya Suzuki; Mitsuhiro Yamada; Toru Takahashi; Chiharu Ota; Mutsuo Yamaya
Journal:  Exp Lung Res       Date:  2011-12-08       Impact factor: 2.459

4.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  Neutrophil elastase inhibitor ameliorates reperfusion injury in a canine model of lung transplantation.

Authors:  T Aoki; M Tsuchida; M Takekubo; M Saito; K Sato; J Hayashi
Journal:  Eur Surg Res       Date:  2005 Sep-Oct       Impact factor: 1.745

6.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

7.  Registry of the Japanese society of lung and heart-lung transplantation: the official Japanese lung transplantation report 2012.

Authors:  Takahiro Oto; Yoshinori Okada; Toru Bando; Masato Minami; Takeshi Shiraishi; Takeshi Nagayasu; Masayuki Chida; Meinoshin Okumura; Hiroshi Date; Shinichiro Miyoshi; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-26

8.  Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation.

Authors:  Michiel E Erasmus; Meine H Fernhout; Jan M Elstrodt; Gerhard Rakhorst
Journal:  Transpl Int       Date:  2006-07       Impact factor: 3.782

9.  Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo.

Authors:  Stig Steen; Qiuming Liao; Per N Wierup; Ramunas Bolys; Leif Pierre; Trygve Sjöberg
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

10.  Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients.

Authors:  Mineji Hayakawa; Kenichi Katabami; Takeshi Wada; Masahiro Sugano; Hirokatsu Hoshino; Atsushi Sawamura; Satoshi Gando
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

View more
  9 in total

1.  Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.

Authors:  Eric J Charles; J Hunter Mehaffey; Ashish K Sharma; Yunge Zhao; Mark H Stoler; James M Isbell; Christine L Lau; Curtis G Tribble; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-12       Impact factor: 5.209

Review 2.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

3.  Protective effect of Shenfu injection preconditioning on lung ischemia-reperfusion injury.

Authors:  Hong Zhang; Zhanhai Wan; Xiang Yan; De-Gui Wang; Yufang Leng; Yongqiang Liu; Yan Zhang; Haijun Zhang; Xuena Han
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

4.  Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation.

Authors:  Salome R T Rehm; Natalia F Smirnova; Carmela Morrone; Jessica Götzfried; Annette Feuchtinger; John Pedersen; Brice Korkmaz; Ali Önder Yildirim; Dieter E Jenne
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

5.  Neutrophil elastase plays a non-redundant role in remodeling the venular basement membrane and neutrophil diapedesis post-ischemia/reperfusion injury.

Authors:  Mathieu-Benoit Voisin; Giovanna Leoni; Abigail Woodfin; Laure Loumagne; Nimesh Sa Patel; Rosanna Di Paola; Salvatore Cuzzocrea; Christoph Thiemermann; Mauro Perretti; Sussan Nourshargh
Journal:  J Pathol       Date:  2019-03-22       Impact factor: 7.996

Review 6.  Novel approaches for long-term lung transplant survival.

Authors:  Cynthia L Miller; Jane M O; James S Allan; Joren C Madsen
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 7.  Review 2: Primary graft dysfunction after lung transplant-pathophysiology, clinical considerations and therapeutic targets.

Authors:  Zhaosheng Jin; Ka Chun Suen; Zhiping Wang; Daqing Ma
Journal:  J Anesth       Date:  2020-07-20       Impact factor: 2.078

Review 8.  Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Mark E Roeser; Irving L Kron; Victor E Laubach
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

Review 9.  The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.

Authors:  Jasper Iske; Christopher A Hinze; Jawad Salman; Axel Haverich; Stefan G Tullius; Fabio Ius
Journal:  Am J Transplant       Date:  2021-08-24       Impact factor: 8.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.